Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
59.03
-0.33 (-0.56%)
Nov 21, 2024, 4:00 PM EST - Market closed
Rhythm Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -258.94 | -184.68 | -181.12 | -69.61 | -134 | -140.73 | Upgrade
|
| Depreciation & Amortization | 1.6 | 1.76 | 1.67 | 1.16 | 0.69 | 0.83 | Upgrade
|
| Loss (Gain) From Sale of Investments | -15.86 | -9.84 | -1.27 | - | - | - | Upgrade
|
| Stock-Based Compensation | 37.8 | 32.55 | 19.83 | 20.8 | 17.46 | 11.88 | Upgrade
|
| Other Operating Activities | 101.72 | 19.24 | 4.87 | -100.25 | -0.23 | 0.2 | Upgrade
|
| Change in Accounts Receivable | -4.77 | -8.64 | -5.2 | -1.25 | - | - | Upgrade
|
| Change in Inventory | -6.13 | -5.71 | -2.81 | -0.01 | - | - | Upgrade
|
| Change in Accounts Payable | 11.6 | 14.77 | 1.54 | 18.31 | -6.45 | 10.51 | Upgrade
|
| Change in Unearned Revenue | - | -0.15 | -6.61 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 8.58 | 4.53 | -4.34 | -15.15 | 0.55 | -5.44 | Upgrade
|
| Operating Cash Flow | -124.42 | -136.16 | -173.43 | -146 | -121.98 | -122.75 | Upgrade
|
| Capital Expenditures | 0 | -0.05 | -0.28 | -0.43 | -0.21 | -3.39 | Upgrade
|
| Sale (Purchase) of Intangibles | -40.5 | -5.67 | - | 7 | - | - | Upgrade
|
| Investment in Securities | -6.19 | 0.05 | 32.31 | -163.73 | 158.75 | -24.59 | Upgrade
|
| Other Investing Activities | - | - | -4 | 95 | - | - | Upgrade
|
| Investing Cash Flow | -46.69 | -5.67 | 28.03 | -62.16 | 158.53 | -27.97 | Upgrade
|
| Issuance of Common Stock | 19.25 | 57.4 | 141.49 | 166.48 | 2.01 | 163.47 | Upgrade
|
| Other Financing Activities | -2.77 | 16.97 | 72.34 | - | - | - | Upgrade
|
| Financing Cash Flow | 155.34 | 74.37 | 213.83 | 166.48 | 2.01 | 163.47 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.17 | -0.14 | - | - | - | - | Upgrade
|
| Net Cash Flow | -16.94 | -67.6 | 68.43 | -41.68 | 38.56 | 12.75 | Upgrade
|
| Free Cash Flow | -124.42 | -136.2 | -173.71 | -146.44 | -122.19 | -126.14 | Upgrade
|
| Free Cash Flow Margin | -110.56% | -175.91% | -734.87% | -4642.90% | - | - | Upgrade
|
| Free Cash Flow Per Share | -2.06 | -2.36 | -3.33 | -2.95 | -2.77 | -3.46 | Upgrade
|
| Levered Free Cash Flow | -143.16 | -91.47 | -105.11 | -57.05 | -72.85 | -74.88 | Upgrade
|
| Unlevered Free Cash Flow | -130.85 | -82.79 | -101.86 | -57.05 | -72.85 | -74.88 | Upgrade
|
| Change in Net Working Capital | -36.2 | -3.83 | 11.11 | -20.71 | 5.42 | -7.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.